SCHEMBL255984

SCHEMBL255984

Bc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388343 0.69
SCHEMBL102331 0.67 PDPK1 (0.59)
SCHEMBL15870899 0.67 RIOK2 (0.49)
SCHEMBL1986516 0.66
SCHEMBL31083943 0.65
SCHEMBL6063 0.65
Aminothiazole SCHEMBL4962431 0.65 ALDH1A1 (1.00)
Aminothiazole SCHEMBL7401 0.65
Aminothiazole SCHEMBL1136755 0.65
SCHEMBL31556353 0.65 PDPK1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105348048-A Method for preparing aryl trifluoroethoxyl ether NAT UNIV DONG HWA 2016-02-24 CN claimed
CN-115197248-B Novel thiazole boron compound and preparation method and application thereof 中国科学院化学研究所 2025-04-25 CN disclosed
CN-115197248-B Novel thiazole boron compound and preparation method and application thereof 中国科学院化学研究所 2025-04-25 CN disclosed
WO-2023187012-A1 COMPOSITIONS INCLUDING AQUEOUS AMINE BORANE COMPLEXES AND POLYNUCLEOTIDES, AND METHODS OF USING THE SAME TO DETECT METHYLCYTOSINE OR HYDROXYMETHYLCYTOSINE ILLUMINA CAMBRIDGE LIMITED (GB) 2023-10-05 WO disclosed
WO-2023185073-A1 PARP7 INHIBITOR AND USE THEREOF 诺沃斯达药业(上海)有限公司 2023-10-05 WO disclosed
WO-2023114379-A1 PLPRO INHIBITORS HUAHAI US INC. (US) 2023-06-22 WO disclosed
EP-4105207-A1 QUINOLYL PHOSPHINE OXIDE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2022-12-21 EP disclosed
CN-115197248-A Novel thiazole boron compound and preparation method and application thereof 中国科学院化学研究所 2022-10-18 CN disclosed
CN-115197248-A Novel thiazole boron compound and preparation method and application thereof 中国科学院化学研究所 2022-10-18 CN disclosed
WO-2021050688-A1 COMPOUNDS AND USES THEREOF X-CHEM, INC. (US) 2021-03-18 WO disclosed
WO-2012078777-A1 BICYCLIC COMPOUNDS AS PIM INHIBITORS AMGEN INC. (US) 2012-06-14 WO disclosed
EP-1363705-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-06-13 EP disclosed
WO-2012028757-A1 FLUORINATED THIAZOLES FOR USE IN TREATING CANCER UNIVERSITAT DE BARCELONA (ES) 2012-03-08 WO disclosed
WO-2011134280-A1 COMPOUNDS AS AGONISTS OF S1P1 RECEPTORS GLAXO GROUP LIMITED (GB) 2011-11-03 WO disclosed
EP-1996180-B1 BENZAMIDE AND PYRIDYLAMIDE DERIVATIVES AS ANTIBACTERIAL AGENTS BIOTA EUROPE LTD (GB) 2011-08-03 EP disclosed
US-7910579-B2 Benzoxazole derivatives TOHOKU UNIVERSITY (JP) 2011-03-22 US disclosed
WO-2009149188-A1 COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY AND FIBROTIC DISORDERS INTERMUNE, INC. (US) 2009-12-10 WO disclosed
WO-2009067600-A2 BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATION DECODE GENETICS EHF (IS) 2009-05-28 WO disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
CN-1390139-A Oncolytic combinations for the treatment of cancer LILLY CO ELI (US) 2003-01-08 CN disclosed